Skip to main content
. 2020 Jan 25;2020(1):CD013128. doi: 10.1002/14651858.CD013128.pub2

Legat 2017.

Methods Study design: randomised controlled trial
Objective: "we investigated the effects of BB‐UVB versus NB‐UVB in reducing pruritus in patients with CP. 49 patients consented and were randomly assigned to BB‐UVB or NB‐UVB"
Participants 38 patients with chronic pruritus
Interventions Phototherapy broad band ‐ UVB vs narrow band ‐ UVB
Outcomes Quote: "reducing the intensity of pruritus in patients with chronic pruritus using a visual analogue scale (VAS) ranging from 0 (= no itch) to 10 (= worst imaginable itch)"
Notes PP74 Abstract from the 9th World Congress on Itch, 15–17 October 2017, Wroclaw, Poland
We sent 3 emails to the study authors (franz.legat@medunigraz.at 11/2018, 01/2019, and 03/2019) with no response. The study does not specify if researchers included patients with CPUO

BB‐UVB: broad band ultraviolet B.

CP: chronic pruritus.

CPUO: chronic pruritus of unknown origin.

N/A: not applicable.

NB‐UVB: narrow band ultraviolet B.

UVB: ultraviolet B.

VAS: visual analogue scale.